Q1 2021 ImpediMed Ltd Earnings Call Transcript
Thank you for standing by, and welcome to the ImpediMed quarterly results investor conference call. (Operator Instructions)
I would now like to hand the conference over to Mr. Richard Carreon, Managing Director and CEO. Please go ahead.
Thank you, Rachel. Welcome, everyone, and thank you for joining us today. We're hosting this conference call to discuss our 4C for the financial quarter ending 30 September, 2020.
With us on the call this afternoon is Tim Cruickshank, our Chief Financial Officer; and Mike Bassett, our Senior Vice President of Corporate and Strategic Development.
I'll be referencing the 4C we lodged this morning, Australian time. At the conclusion of my remarks, we'll be taking questions.
Today, we'll be discussing our first quarter results for 2021 financial year. We have made great strides over the quarter, and we are confident that the key drivers are in place to accelerate the adoption of the SOZODigital Health Platform over
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |